NCT03875378View on ClinicalTrials.gov

Transdermal Estrogen in Women With Anorexia Nervosa

PHASE2RecruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

August 28, 2020

Primary Completion Date

August 31, 2028

Study Completion Date

December 31, 2028

Conditions
Anorexia Nervosa
Interventions
DRUG

Transdermal estrogen

Transdermal estradiol (0.045mg)/levonorgestrel (0.015mg) weekly patch

DRUG

Placebos

Placebo weekly patch

Trial Locations (1)

15213

RECRUITING

University of Pittsburgh School of Medicine, Pittsburgh

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Pouneh K. Fazeli, MD

OTHER